Historical Stock Price
LOXO historical stock prices picture
LOXO (LOXO) has the following price history information. Looking back at LOXO historical stock prices for the last five trading days, on February 11, 2019, LOXO opened at $234.50, traded as high as $234.59 and as low as $234.43, and closed at $234.50. Trading volume was a total of 781.70K shares. On February 12, 2019, LOXO opened at $234.59, traded as high as $234.78 and as low as $234.45, and closed at $234.71. Trading volume was a total of 296.10K shares. On February 13, 2019, LOXO opened at $234.71, traded as high as $234.93 and as low as $234.61, and closed at $234.73. Trading volume was a total of 268.10K shares. On February 14, 2019, LOXO opened at $234.70, traded as high as $234.88 and as low as $234.66, and closed at $234.66. Trading volume was a total of 783.30K shares. On February 15, 2019, LOXO opened at $234.66, traded as high as $234.66 and as low as $234.66, and closed at $234.66. Trading volume was a total of 400 shares.

LOXO Historical Stock Prices By Date:

LOXO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into LOXO shares, starting with a $10,000 purchase of LOXO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/04/2014
End date: 02/15/2019
Start price/share: $13.02
End price/share: $234.66
Dividends collected/share: $0.00
Total return: 1,702.30%
Average Annual Total Return: 89.15%
Starting investment: $10,000.00
Ending investment: $180,246.40
Years: 4.54
Date Open High Low Close Volume
02/11/2019 $234.50 $234.59 $234.43 $234.50 781.70K
02/12/2019 $234.59 $234.78 $234.45 $234.71 296.10K
02/13/2019 $234.71 $234.93 $234.61 $234.73 268.10K
02/14/2019 $234.70 $234.88 $234.66 $234.66 783.30K
02/15/2019 $234.66 $234.66 $234.66 $234.66 400
Loxo Oncology is a biopharmaceutical company engaged in the development of selective medicines for patients with genetically defined cancers. Co.'s main product candidate is Larotrectinib, an oral, selective inhibitor of the tropomyosin receptor kinase (TRK) family in development for the treatment of tumors with TRK fusions. Co.'s drug candidate, LOXO-195 is designed as a second-generation TRK inhibitor intended to address predicted acquired resistance mechanisms resulting from therapy with a first-generation TRK inhibitor such larotrectinib, or multikinase inhibitors with anti-TRK activity. Co.'s LOXO-292 targets a cancer oncogene known as Rearranged during Transfection.
Date Close
02/11/2019$234.50
02/12/2019$234.71
02/13/2019$234.73
02/14/2019$234.66
02/15/2019$234.66
LOXO is categorized under the Healthcare sector; below are some other companies in the same sector:

LPCN Historical Stock Prices
LPDX Historical Stock Prices
LPNT Historical Stock Prices
LPTN Historical Stock Prices
LPTX Historical Stock Prices
LUX Historical Stock Prices
LXRX Historical Stock Prices
MACK Historical Stock Prices
MAKO Historical Stock Prices
MASI Historical Stock Prices

Also explore: LOXO shares outstanding history

Email EnvelopeFree LOXO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


LOXO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.